HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 198 filers reported holding HERON THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 2.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $324 | -6.4% | 314,826 | +5.5% | 0.00% | 0.0% |
Q2 2023 | $346 | +1093.1% | 298,359 | +1402.2% | 0.00% | – |
Q1 2023 | $29 | -43.1% | 19,862 | -3.6% | 0.00% | – |
Q4 2022 | $51 | -99.9% | 20,612 | -2.5% | 0.00% | – |
Q3 2022 | $89,000 | +93.5% | 21,137 | +27.9% | 0.00% | – |
Q2 2022 | $46,000 | -29.2% | 16,522 | +43.4% | 0.00% | – |
Q1 2022 | $65,000 | -38.1% | 11,522 | -0.7% | 0.00% | – |
Q4 2021 | $105,000 | -68.4% | 11,602 | -62.6% | 0.00% | -100.0% |
Q3 2021 | $332,000 | -31.8% | 31,060 | -1.2% | 0.00% | 0.0% |
Q2 2021 | $487,000 | -2.8% | 31,431 | +1.7% | 0.00% | 0.0% |
Q1 2021 | $501,000 | -12.9% | 30,915 | +13.6% | 0.00% | -50.0% |
Q4 2020 | $575,000 | +38.6% | 27,209 | -2.9% | 0.00% | +100.0% |
Q3 2020 | $415,000 | -6.1% | 28,028 | -6.9% | 0.00% | -50.0% |
Q2 2020 | $442,000 | +127.8% | 30,095 | +81.4% | 0.00% | +100.0% |
Q1 2020 | $194,000 | -32.4% | 16,589 | +35.4% | 0.00% | 0.0% |
Q4 2019 | $287,000 | +29.3% | 12,250 | +1.7% | 0.00% | 0.0% |
Q3 2019 | $222,000 | – | 12,050 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 21,288 | $250,000 | 19.87% |
TANG CAPITAL MANAGEMENT LLC | 2,896,904 | $34,010,000 | 4.78% |
PFM Health Sciences, LP | 2,481,917 | $29,138,000 | 2.39% |
Iron Triangle Partners LP | 500,000 | $5,870,000 | 2.27% |
NEXPOINT ASSET MANAGEMENT, L.P. | 777,599 | $9,129,000 | 1.72% |
Pekin Hardy Strauss, Inc. | 588,732 | $6,912,000 | 1.55% |
First Light Asset Management, LLC | 691,400 | $8,117,000 | 1.39% |
Congress Park Capital LLC | 111,045 | $1,304,000 | 1.18% |
Mesirow Financial Investment Management, Inc. | 15,135 | $178,000 | 1.12% |
Elk Creek Partners, LLC | 509,174 | $5,978,000 | 1.03% |